Variable | All patients (N = 314) | NSCRC (N = 188) | SCRC (N = 126) | |||
---|---|---|---|---|---|---|
p | HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | |
Univariate analysis | ||||||
sTILs | 0.000 | 0.553 (0.398–0.769) | 0.002 | 0.499 (0.321–0.776) | 0.162 | 0.704 (0.431–1.151) |
iTILs | 0.497 | 1.413 (0.521–3.831) | 0.949 | 1.047 (0.256–4.281) | 0.201 | 2.533 (0.609–10.546) |
CD3* | 0.001 | 0.478 (0.307–0.745) | 0.012 | 0.518 (0.309–0.868) | 0.014 | 0.318 (0.127–0.796) |
CD20* | 0.007 | 0.613 (0.428–0.877) | 0.029 | 0.600 (0.379–0.950) | 0.044 | 0.573 (0.333–0.985) |
Age (< 60 years) | 0.013 | 1.731 (1.124–2.666) | 0.156 | 1.410 (0.877–2.268) | 0.232 | 21.827 (0.139–3436.270) |
Gender (male/female) | 0.013 | 1.562 (1.100–2.216) | 0.022 | 1.738 (1.082–2.790) | 0.307 | 1.311 (0.779–2.207) |
Tumor size (5 cm) | 0.834 | 1.036 (0.746–1.437) | 0.526 | 0.864 (0.550–1.357) | 0.320 | 1.282 (0.786–2.089) |
Tumor site | ||||||
Rectum | Refer | Refer | Refer | |||
Left colon | 0.908 | 1.025 (0.676–1.553) | 0.677 | 0.891 (0.516–1.537) | 0.539 | 1.229 (0.636–2.376) |
Right colon | 0.501 | 0.869 (0.578–1.307) | 0.054 | 0.587 (0.341–1.010) | 0.128 | 1.636 (0.867–3.084) |
Pathological T stage | 0.000 | 2.596 (1.565–4.307) | 0.001 | 3.375 (1.625–7.008) | 0.087 | 1.851 (0.915–3.747) |
Lymph node metastasis | 0.000 | 2.793 (2.002–3.895) | 0.000 | 2.469 (1.581–3.856) | 0.000 | 3.552 (2.141–5.894) |
TNM stage | 0.000 | 3.216 (2.279–4.537) | 0.000 | 2.797 (1.765–4.434) | 0.000 | 4.219 (2.479–7.128) |
Tumor differentiation | 0.000 | 1.879 (1.326–2.662) | 0.003 | 2.013 (1.260–3.216) | 0.054 | 1.668 (0.991–2.809) |
Lymphangio | 0.000 | 2.038 (1.467–2.832) | 0.000 | 2.829 (1.811–4.419) | 0.275 | 1.321 (0.801–2.180) |
Nervous invasion | 0.143 | 1.492 (0.873–2.552) | 0.327 | 1.417 (0.706–2.844) | 0.500 | 1.727 (0.741–4.024) |
Tumor deposit | 0.000 | 3.979 (2.667–5.936) | 0.000 | 3.967 (2.353–6.688) | 0.000 | 4.138 (2.205–7.769) |
Colonic perforation | 0.813 | 0.887 (0.328–2.397) | 0.767 | 1.190 (0.375–3.670) | 0.508 | 0.506 (0.070–3.657) |
Tumor budding (≤ 5 cells) | 0.001 | 1.877 (1.297–2.715) | 0.000 | 2.500 (1.492–4.188) | 0.421 | 1.247 (0.729–2.134) |
Schistosomiasis | 0.049 | 1.390 (1.001–1.929) | — | — | — | — |
Ulceration | 0.617 | 0.919 (0.659–1.281) | 0.743 | 1.077 (0.690–1.681) | 0.212 | 0.725 (0.437–1.201) |
Histological type | 0.705 | 1.096 (0.683–1.757) | 0.280 | 1.403 (0.759–2.594) | 0.467 | 0.760 (0.362–1.594) |
Multivariate analysis | ||||||
Gender | 0.001 | 1.886 (1.295–2.746) | 0.021 | 1.812 (1.093–3.004) | — | |
TNM stage | 0.000 | 2.099 (1.403–3.139) | — | — | 0.000 | 3.703 (2.149–6.381) |
Tumor budding (≤ 5 cells) | — | — | 0.050 | 1.647 (0.988–2.745) | — | — |
Tumor differentiation | 0.039 | 1.499 (1.021–2.203) | 0.021 | 1.826 (1.095–3.044) | — | |
CD3* | 0.003 | 0.481 (0.297–0.781) | 0.026 | 0.525 (0.297–0.927) | 0.045 | 0.404 (0.160–1.021) |
sTILs | 0.031 | 0.660 (0.452–0.963) | 0.034 | 0.570 (0.339–0.959) | — | — |
Lymphangio | 0.012 | 1.580 (1.106–2.256) | 0.006 | 1.994 (1.223–3.252) | — | — |
Tumor deposit | 0.000 | 2.818 (1.743–4.555) | 0.000 | 3.837 (2.053–7.170) | — | — |